Debt-to-equity of Jasper Therapeutics, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Jasper Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Jasper Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 74%, a 373% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Jasper Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 74% +58% +373% 30 Sep 2025
Q2 2025 34% +19% +124% 30 Jun 2025
Q1 2025 22% +6.8% +46% 31 Mar 2025
Q4 2024 17% +2% +14% 31 Dec 2024
Q3 2024 16% +0.22% +1.4% 30 Sep 2024
Q2 2024 15% -0.83% -5.1% 30 Jun 2024
Q1 2024 15% -3.3% -18% 31 Mar 2024
Q4 2023 15% -8% -35% 31 Dec 2023
Q3 2023 15% -9.1% -37% 30 Sep 2023
Q2 2023 16% -12% -42% 30 Jun 2023
Q1 2023 18% -30% -62% 31 Mar 2023
Q4 2022 23% -130% -85% 31 Dec 2022
Q3 2022 24% +152% 30 Sep 2022
Q2 2022 28% +56% 30 Jun 2022
Q1 2022 49% +76% 31 Mar 2022
Q4 2021 153% +185% 31 Dec 2021
Q3 2021 -128% -85% -201% 30 Sep 2021
Q2 2021 -28% 30 Jun 2021
Q1 2021 -28% 31 Mar 2021
Q4 2020 -31% 31 Dec 2020
Q3 2020 -43% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.